<DOC>
	<DOC>NCT00395044</DOC>
	<brief_summary>This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.</brief_summary>
	<brief_title>Gabapentin Treatment of Cannabis Dependence</brief_title>
	<detailed_description>This is a 12-week, double blind, placebo controlled, dose ranging study to evaluate the efficacy of gabapentin in treating outpatients with cannabis dependence. Counseling and research assessments occur weekly throughout the 12-week treatment phase.</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Males or females age 1865 with cannabis dependence Meets DSMIVTR criteria for Cannabis Dependence Smoked marijuana at least once a week in the 90 days prior to study participation Willing to attend 12 weekly study visits and 1 followup visit Currently meets DSMIVTR criteria for dependence on illicit substances other than cannabis Significant medical disorders that will increase potential risk or interfere with study participation Women with childbearing potential who are pregnant, nursing, or refuse to use a reliable method of birth control Treatment with an investigational drug in the last month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Cannabis treatment</keyword>
	<keyword>marijuana treatment</keyword>
</DOC>